Monitoring adherence to the therapy of asthma

Current Opinion in Allergy and Clinical Immunology

Volumn 2, Issue 3, 2002, Pages 201-205

  Milgrom, Henry ^a   Wamboldt, Frederick ^a   Bender, Bruce ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ASTHMA; CLINICAL FEATURE; DEVICE; DISEASE EXACERBATION; DOSE RESPONSE; HEALTH CARE QUALITY; MEDICAL DECISION MAKING; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; RELIABILITY; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036277579     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200206000-00008     Document Type: Review

References (35)

1. Mis- and non-use of prescription drugs: Confusion, lost revenues and future commercial opportunities
2. Treatment adherence improves outcomes and manages costs
3. Non-compliance and treatment failure in children with asthma
4. Methods of assessing and improving patient compliance in clinical trials
5. Predictors of persistence of use of the novel antidiabetic agent acarbose
6. Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma
7. Asthma guidelines: An assessment of physician understanding and practice
8. Why don't physicians follow clinical practice guidelines? A framework for improvement
9. Short-term outcomes after acute treatment of pediatric asthma
10. Assessing the quality of asthma care provided to Medicaid patients enrolled in managed care organizations in Connecticut
11. Patient self-management of acute asthma: Adherence to national guidelines a decade later
12. Provider adherence to a clinical practice guideline for acute asthma in a pediatric emergency department
13. Telephoning the patient's pharmacy to assess adherence with asthma medications by measuring refill rate for prescriptions
14. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers
15. Stratifying asthma populations by medication use: How you count counts
16. Inhaled steroids and the risk of hospitalization for asthma
17. Low-dose inhaled corticosteroids and the prevention of death from asthma
18. Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT
19. Short-term compliance with peak flow monitoring: Results from a study of inner city children with asthma
20. Accuracy of children's self-reported adherence to treatment
21. Electronic compliance monitoring in resistant hypertension: The basis for rational therapeutic decisions
22. Nonadherence to asthma treatment and failure of therapy
23. High-dose inhaled steroid therapy for asthma
24. Long-term effects of budesonide or nedocromil in children with asthma
25. How much compliance is enough?
26. Patient non-compliance with drug regimens: Measurement, clinical correlates, economic impact
27. Accounting for noncompliance in pharmacoeconomic evaluations
28. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: A randomized controlled trial
29. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: A randomized controlled trial
30. Immune control of HIV-1 after early treatment of acute infection
31. Development and implementation of the home asthma telemonitoring (HAT) system to facilitate asthma self-care
32. Potentially inappropriate medication use in the community-dwelling elderly: Findings from the 1996 Medical Expenditure Panel Survey
33. Improving drug use in elderly patients: Getting to the next level